The tips, put together by Tessa Plagis (communication advisor at St. Anna Advies), Alan Robinson (director of VetDynamics) and Rebecca Robinson (coach at VetDynamics and senior clinician in veterinary anaesthesia at the AHT), are being shared to set the scene for Congress 2023, where international experts will be exploring how time management at organisational, systems, teams and an individual levels can lead to drastic improvements in performance, job satisfaction and wellbeing.
The Association points to the demands on the profession caused by the fact that veterinary professionals have been saying 'yes' to everything for years: yes to more clients, more patients and more overtime.
This, says BSAVA, is taking its toll: experienced practitioners and recent graduates are leaving the profession, and many more are suffering mental and physical health issues associated with sustained high stress.
Tessa Plagis, communication advisor at St. Anna Advies, said: “We are at a tipping point and can’t keep doing what we’ve always done. If we want sustainable veterinary businesses going forward we need to change the structure of how we work.”
Tessa says the issues are both organisational and individual: “Many veterinary professionals struggle to give boundaries.
"We are people pleasers and tend to say ‘yes’, even if that means compromising other important aspects of lives, such as family.
"This set against a background of too few vets, which means that there’s nobody to help us out when there’s too much to-do.”
To find out more about time management, book your ticket for BSAVA Congress at: https://www.bsavaevents.com/bsavacongress2023/en/page/home, and in the meantime, here are Tessa, Alan and Rebecca's time management tips.
Tessa's tips
Alan's tips
Rebecca's tips
The equine events will initially take place at Rossdales Equine Hospital in Suffolk on 22nd October and at Ashbrook Veterinary Hospital in Cheshire on 5th December.
The roadshow will see a range of speakers renowned in the fields of equine veterinary medicine and QI share practical examples of improving outcomes for equine patients. Interactive workshops, real-life scenarios and case studies will show how QI techniques can be applied in practice to help teams prevent and respond to errors.
Confirmed speakers include Professor Debra Archer, Head of Equine Surgery and Professor in Equine Surgery at the University of Liverpool, Dr Alice Bird, Senior Clinical Anaesthetist at the Animal Health Trust and Dr Rachel Dean, Director of Clinical Research and Excellence in Practice, VetPartners.
President Elect of BEVA, Tim Mair, said: "There are many challenges to being an equine vet and running a successful equine practice. Even in large practices and equine hospitals, there is a risk that we operate in our own little bubble and assume that what we are doing is best practice, whereas in reality we could often do a better job.
"Clinical governance and quality improvement are tools that allow us to critically appraise our day-to-day work and identify ways in which we can continuously improve what we do – to the benefit of our patients and clients, as well as to ourselves."
The canine hip dysplasia roadshow will begin on 9th October in Gatwick, Surrey.
The event will review the condition prevalent in dogs, how best to investigate it and the available treatment options. Case examples will be used to show how the evidence can be evaluated, explain how to measure treatment outcomes and show how the use of checklists can help minimise potential errors.
It will be hosted by Mark Morton, RCVS Specialist in Small Animal Surgery (Orthopaedics). He said: "As vets we probably all undertake bits of QI on a day-to-day basis (whether we realise it or not!) but there is so much more we can do to embed it into our clinical work. Checklists, treatment guidelines and clinical auditing significantly improve our patient care and our outcomes.
"Whilst looking at hip dysplasia and the treatment options in detail, hopefully this roadshow will show how we can apply these ideas to improve our management of this condition as well as using them elsewhere.”
For the full programme of each event and to buy tickets, visit bit.ly/RCVSKnowledgeEvents.
Anyone interested in booking an RCVS Knowledge roadshow for their region can do so by contacting ebvm@rcvsknowledge.org.
As part of the new arrangement, Battersea will give StreetVet operational and logistical support, including advice from its staff, clinical support, and kennel space for animals in urgent need of care.
Battersea also plans to work with StreetVet on a range of projects that will help the charity to reach more dogs in need. For example, providing advice and training to hostel staff to promote and facilitate hostels accepting dogs – creating more safe places to sleep for both dogs and their owners.
Battersea’s Deputy Chief Executive, Peter Laurie, said: "I’m excited at the prospect of Battersea and StreetVet coming together for a partnership that aligns both organisations’ strategic values. Both of us care deeply about the welfare of dogs, particularly those most in need. StreetVet relies almost entirely on the support of a growing network of volunteers, including members of the Battersea clinic team, and is a great example of a volunteer-led organisation delivering significant impact on a wide geographical scale. By working together, we can increase our collective impact and help more animals in need."
Sam Joseph MRCVS, a co-founder of StreetVet, said: "We are really excited about the official partnership between StreetVet and Battersea. As a small, growing charity, StreetVet will hugely benefit from the expertise, infrastructure and resources of one of the country's most loved and respected animal charities."
He added: "This partnership will help StreetVet continue to provide free, accessible veterinary care to those most in need, while further increasing the impact that Battersea has on the welfare of dogs and cats across the UK."
Photo: L-R Peter Laurie (Battersea), Jade Statt and Sam Joseph (StreetVet), Shaun Opperman (Battersea) and Blue the Staffie
Apoquel chewable tablets were approved by the Veterinary Medicines Directorate (VMD) in November 2021.
Apoquel Chewable contains the same active ingredient, at the same dosing regime, for the same indications as original Apoquel, but in a palatable formulation which, in a field-study of client-owned dogs, was found to have a 91.6% acceptance rate.1
Dr Carly Mason, President of the British Veterinary Dermatology Study Group (BVDSG), said: “The new chewable form of Apoquel provides owners with a means of controlling itch using a tablet that can be given like a treat or mixed with a meal, making it much easier for owners and more acceptable to their pet.
“In many cases, the chewable formulation will be the obvious first-line Apoquel for veterinarians to prescribe to control canine itching while the underlying cause of allergic dermatitis is investigated.”
Reference
Noel Fitzpatrick of Channel 4 Supervet fame has been presented with an award by Guinness World Records after performing the world's first double 'bionic' leg implant on a cat.
The procedure, which was carried out on a cat called Oscar in 2009, was also the first time such implants had been placed into a moving joint.
The award was presented to Noel by Craig Glenday, Editor In Chief of Guinness World Records, at the London Pet Show.
Noel said: "The Guinness Book of Records was the first book I ever had, so receiving this award is a real honour! I'm very humbled, you're only as good as your next operation - you only ever think about providing hope to pets and their owners and doing your best. To be able to help them through the toughest times and see pets like Oscar make a full recovery is the most rewarding feeling and I'm thrilled that the work we carry out at Fitzpatrick Referrals has been recognised by Guinness World Records."
Vetswest, the veterinary support services company, has been acquired by MWI Veterinary Supply, a subsidiary of the US multinational, AmerisourceBergen.
MWI already owns Centaur and VetSpace, and the agreement will allow it to further expand the range of services it offers the animal health profession in the UK.
Jim Cleary, Executive Vice President of AmerisourceBergen and President of MWI Veterinary Supply said: “This partnership reflects our commitment to the success of veterinary practices across the globe. We’re proud to welcome Vetswest to the MWI family as we continue to expand our services in our mission to be the best resource to the animal health profession.”
Vetswest offers group business support services for its 235 member veterinary practices including negotiating manufacturer terms and a proprietary IT system that supports pricing intelligence, inventory information and reporting on purchasing activity. The company also provides access to ancillary services for veterinary surgeons to help manage human resources, continuing professional development, insurance offerings, pension services and other areas which support the growth of member practices.
Vetswest's retiring managing director David Buckley said: “The resources of MWI and AmerisourceBergen will allow us to bring new innovation to the market and additional benefits to Vetswest members. I’m excited about Vetswest’s future under the leadership of Chris Sobey and as part of the MWI and AmerisourceBergen family.”
Chris Sobey, who will become the new managing director of Vetswest following his tenure as Vetswest’s business development director said: “Our goal has always been to improve efficiencies and services for our members through scale and with our new relationship with MWI and AmerisourceBergen, we will be well positioned to further this core mission of our organisation.’’
Vetoquinol has announced the launch of Enisyl-FTM, the first L-Lysine supplement developed for veterinary use in the UK and Ireland.
Vetoquinol says a unique distributing pump and paste formulation will aid compliance in cats that require L-Lysine supplementation and make administration of L-Lysine much easier. Each pump action delivers 1ml of Enisyl-F paste at each press, which can be applied directly into the cat's mouth or on the paw to be licked off. It can also be added to food.
Zorica Agbaba, Enisyl-F's Product manager said: "We are delighted to have launched Enisyl-F and I am sure it will prove very useful to veterinary surgeons, especially when it comes to aiding compliance in cats that require L-Lysine supplementation."
To try Enisyl-F or for more information about the product, contact your local Vetoquinol representative or call Vetoquinol main office on 01280 814 500 (UK) or 1800 406 117 (ROI free phone number). Alternatively visit http://www.vetoquinol.co.uk/ website.
The winners and runners up will be honoured at a ceremony taking place on the eve of BSAVA Congress on 3rd April 2019.
Matt Baker, presenter of The One Show and Countryfile, will be hosting the Ceva Animal Welfare Awards alongside the head judge, Chris Laurence MBE FRCVS, who puts his name to the Vet of the Year Award.
The award categories include:
Chris Laurence Vet of the Year – sponsored by Vet Record
Vet Nurse of the Year – sponsored by Agria Pet Insurance
Charity Team of the Year – sponsored by PDSA
Charitable Contribution of the Year – sponsored by Blue Cross
International Cat Care Welfare of the Year – sponsored by International Cat Care
Farmer of the Year – sponsored by R.A.B.I.
Farm Educator of the Year – sponsored by NADIS
Outstanding Contribution to Animal Welfare – sponsored by Your Dog and Your Cat magazines
To nominate someone for an award, visit www.cevawelfareawards.com. They can come from all walks of life and will be assessed on the evidence provided in the original nomination.
Entries must be in by Friday 25 January 2019.
Samantha, who was a recipient of the Malaysian Prime Minister’s Scholarship, has a degree in genetics, molecular biology and microbiology, and a PhD in cancer research from University College London.
She was diagnosed with ADHD at the age of 40, which led her to set up ADHD Girls, an organisation that helps people with ADHD access employment and works with businesses to help them understand ADHD.
Samantha's talk is part of a module on neurodiversity, which will open with an exploration of neurodiversity and the challenges of diagnosis, before looking at how you can better support those in practice teams, as well as neurodivergent clients and students.
The session will wrap up with a discussion about how to cultivate greater inclusivity and understanding around those who are neurodivergent within the veterinary professions.
Being neurodivergent means that your brain works differently from the average person, meaning there may be differences in social preference, ways of communicating, ways of learning and ways of perceiving the environment.
Samantha said: “No two brains are the same. But what if you were born with a brain that constantly makes you feel like everything you do differentiates you from everyone else?”
“My talk introduces neurodiversity in the context of society, casting light on ADHD and autism, and how this impacts the workplace and one’s quality of life, and what we can do to build a compassionate culture, starting with the conversations we have at work.
"I’m really excited to talk at the BSAVA Congress and meet other professionals in the veterinary field.”
After her lecture, she will be partaking in a panel discussion around the challenges of diagnosis of neurodivergence alongside Laura Playforth, a vet who has been diagnosed with both bipolar and autism and is currently Group Quality Improvement Director at IVC Evidensia.
Andy Green, Vice Chair of the BSAVA Congress Programme Committee chair said: “We are delighted to have Samantha delivering our keynote this year on such an important topic.
"Neurodiversity is becoming an increasingly important area of focus and understanding across society and we have a significant population of neurodivergent people working as vets, nurses and in other roles, many of whom may not as yet have a diagnosis.”
“We also need to recognise that many pet owners and clients are neurodivergent.
"Samantha is ideally placed to shine a spotlight on this subject, using her own story and life experience to deliver a greater understanding of what it actually means to be neurodivergent and how businesses/practices can understand, embrace and support neurodivergent members of the work force and community.”
Early bird tickets for BSAVA Congress 2023 are currently on sale with 3-day and 1-day tickets available to purchase. Get your ticket now: https://www.bsavaevents.com/bsavacongress2023/en/page/home.
Research amongst veterinary surgeons by Janssen Animal Health, maker of Cavalesse oral and Cavalesse topical, has revealed that owners could be doing more harm than good when it comes to managing sweet itch in their horses.
92% of vets questioned are aware that people follow old wives' tales by administering lotions and potions such as garlic and olive oil to ward off flies during the summer sweet itch season, when garlic actually has the opposite effect of attracting them.
According to Janssen, it is thought that only a quarter of horse owners are aware that it is important to carry out preventative measures before the start of the midge season to help alleviate sweet itch. 14% of people are thought to go to their vet for advice on sweet itch, while 30% seek help from their country store or tack shop, 27% search for information on websites and 26% ask other horse owners for guidance. This is despite the fact that 92% of those questioned believe that sweet itch would clear up quicker if people sought advice from their veterinary surgeon.
Nicki Glen, marketing manager at Janssen Animal Health said: "Sweet itch can be an incredibly difficult and frustrating condition to manage, however horse owners do not tend to seek advice from their vets. It is therefore important to educate horse owners while you are on yard visits with pro-active advice on the condition for the long-term health and welfare of horses."
Cavalesse is a natural food supplement containing a specialised formulation of water-soluble vitamins and minerals, including nicotinamide. Once a month the contents of each sachet are dissolved in water to form an oral solution, which can be administered daily via a special pipette, either by sprinkling over a small handful of feed or adding to a treat such as a sugar lump. Janssen says the supplement helps horses maintain a healthy skin and promotes normal immune function in horses prone to summer allergies.
Cavalesse Topical is a skincare gel that can be used in combination with the Cavalesse solution. The gel can be applied to the skin to help support natural immunity from the outside, whilst the oral solution works in partnership from the inside.
For further information on Cavalesse and Cavalesse Topical please contact your Janssen Animal Health account manager or phone 01494 567555.
The one-day event, called VetQuest, will allow prospective students to spend the day being mentored by a current student whilst getting involved in interactive sessions, such as large animal skills, clinical skills and veterinary public health.
Participants will learn about the opportunities available to those interested in pursuing a veterinary career, have a tour of the school and attend talks on vet admissions and work experience.
Dr Louisa Slingsby, Teaching Fellow and Faculty Admissions and Recruitment Officer at the Bristol Vet School, said: "VetQuest allows those who are interested in a career in the veterinary professions to come along for a day to find out more about the roles of veterinary surgeons and veterinary nurses.
"They will also have the opportunity to learn what to think about when choosing and applying for courses and how to give themselves the best possible chance to make an informed decision about if vet medicine is the career for them."
There will also be an optional session for parents and carers to help them navigate the challenges of applying to study to be a vet or vet nurse. The morning starts with a tour and then a talk and a Q&A session and finishes around lunchtime.
The cost of the one-day event is £50 and there are a limited number of subsidised places at £10. Lunch is included in the registration fee. To book visit https://www.bristol.ac.uk/vetscience/events/2018/vetquest-2018.html.
The event is primarily aimed at years 11 and 12, although anyone is welcome to attend.
For further information about VetQuest, email: svs-vetquest@bristol.ac.uk or tel: +44 (0)117 928 9280.
Earlier this year, the RCVS Council approved the roll-out of a more outcomes-based model of CPD to encourage veterinary professionals to engage in greater reflection on learning and development, and the impact that it has on their professional practice.
To support this approach, Council also approved the development of a new CPD recording platform designed to be more intuitive and to make it easy to record CPD in real time.
The College says the new platform – which has the working title of 'One CPD' – will be a ‘one stop shop’ CPD management solution for veterinary surgeons and nurses at all stages of their careers, including veterinary students and student veterinary nurses.
Richard Burley, RCVS Chief Technology Officer, said: "We’re excited to open up access to this powerful, next-generation, tool we’ve been building and welcome our members into an important phase of the development process. Testing with our members will be absolutely critical in delivering the very best experience possible for all those that use 'One CPD' in the future. Ease of use and truly valuable functionality are key deliverables for us and both these need the feedback of our members to perfect."
Dr Linda Prescott-Clements, RCVS Director of Education (pictured right), added: "The first stage of the development of the CPD recording platform is due to finish in October and so we are looking for a cohort of both veterinary surgeons and nurses who can spend a few months this autumn using the new platform to record and reflect on their CPD, in order to test out some of the new features which aim to make this process so much easier to do. We will consider their feedback carefully in order to improve the recording platform ready for launch in January 2020.
"The new ‘One CPD’ platform will ultimately replace the current Professional Development Record, and its use will become mandatory for recording CPD from January 2022.
"In addition to setting up the testing group, we are also looking to meet with key CPD providers for veterinary surgeons and veterinary nurses over the coming months to discuss our plans for outcomes-based CPD and the development of the recording platform in greater detail."
Veterinary surgeons who'd like to take part in the testing for the CPD app, as well as CPD providers who want to discuss the College’s CPD policy plans, should contact Jenny Soreskog-Turp, RCVS CPD Officer, on cpd@rcvs.org.uk or 020 7202 0701.
The new tool uses aggregated data from Banfield Pet Hospital medical records to identify whether a dog has a high, medium, or low risk of having PD based on the breed size1,2,3,4,5, age, and body condition the owner has stated3,4.
It also makes oral care recommendations based on the dog's history (e.g., diet, previous extractions, halitosis), clinical signs (e.g., bleeding gums) and current dental routine (e.g., tooth brushing).
Global Petcare R&D VP at Mars Pet Nutrition, Dr. Elise Malandain said: “This new risk assessment tool will help indicate to pet owners what level of risk their pet is at for developing this disease to help inform conversations with veterinary professionals about prevention or treatment.”
https://www.uk.pedigree.com/gum-disease-risk-checker
References
The website now contains a range of information on Alfaxan including user experiences, sections on best practice anaesthesia, webinars and details of Jurox’s anaesthesia roadshows.
The webinars include a presentation which explains how to use Alfaxan to achieve the best anaesthetic experience for the patient. There is also series of short online webinars on rabbit anaesthesia:
An online CPD certificate will be issued to veterinary professionals who have viewed each webinar, after they have taken a short online questionnaire.
The Alfaxan website also offers downloadable resources such as the new Considerations for Anaesthetising Rabbits expert panel guidelines booklet, AVA Anaesthetic Safety Checklist Implemenation manual, AVA Anaesthetic Safety Checklist and Alfaxan resource guides, user guides, dose charts and monitoring charts.
Richard Beckwith, country manager of Jurox (UK) Ltd, said: "Our new Alfaxan website is an educational hub that enables veterinary professionals to learn more about best practice anaesthesia and how this can be implemented in their own clinics. With Alfaxan’s new pet rabbit indication we have included an emphasis on rabbit anaesthesia and how this differs from anaesthesia in cats and dogs."
For further information, visit www.alfaxan.co.uk, contact your local Jurox technical sales representative, telephone the customer services team on 0800 500 3171 or e-mail: info@jurox.co.uk.
The programme for the day includes a talk by Matt Rendle, an exotics veterinary nurse, about wound healing in reptiles and the work of the Veterinary Wound Library.
There are also talks about current veterinary practice concerning Chelonia (with a focus on egg retention), the Asian turtle crisis, zoo conservation work, reptile rescue work and perceptions of Chelonia in captivity.
Tickets cost £30-£50, and include refreshments, lunch and optional Sunday workshops.
For more details or to reserve your place, email: turtlesurvivaleurope@gmail.com, or visit: https://www.turtlesurvival.eu/
Virbac Animal Health has launched CaniLeish, the first vaccine for canine leishmaniosis in the European Union.
Leishmaniosis is a vector-borne parasitic disease caused by infection with protozoa of the genus Leishmania (L infantum in Europe). Leishmaniosis is transmitted by the bite of infected sandflies. In south-western Europe 2.5 million dogs are believed to be infected1,2 with the parasite and the disease is spreading northwards,3 as more people travel with their dogs or import infected animals from endemic areas.4 So far preventative methods have been limited to reducing the habitat of sandflies, minimising the physical contact of dogs with sandflies and using insecticides on dogs (sprays, spot-ons, repellent-collars, etc).
According to Virbac, CaniLeish's ability to protect dogs was demonstrated in an experimental challenge study, where the benefit of vaccination was still evident after one year.5 In an extreme condition natural challenge trial lasting two years under environmental conditions rarely encountered in reality, 93% of dogs vaccinated with CaniLeish did not develop symptomatic leishmaniosis. CaniLeish provides a fourfold reduction in the risk of developing this fatal disease. 6 Its safety profile has been shown in laboratory testing and field trials.7 In addition, Virbac says it contains no whole parasites that could be virulent in any host.
David McGahie BVMS Bsc (VetSci) MRCVS, Medical Department Manager at Virbac SA, said: "The development of this vaccine is a key milestone in the battle against this challenging disease which is a major problem in many regions of the world. Although in the past it was considered a rather exotic disease here in the UK, the advent of the Pet Travel Scheme means it has become increasingly important as a problem for dogs which regularly travel abroad to endemic regions."
CaniLeish can be given to dogs as young as six months of age: the primary course consists of three injections given over six weeks. Dogs should be re-vaccinated annually, with a single dose administered one year after the third injection and annually thereafter.
References:
The authors say that an association between acute kidney injury and general anaesthesia is well-defined in human medicine, but there is little information in the veterinary literature.
In their new study, called “Twelve previously healthy non-geriatric dogs present for acute kidney injury after general anaesthesia for non-emergency surgical procedures in the UK1”, Emma Rogers-Smith and her co-authors retrospectively analysed the medical records of 12 dogs that presented for acute kidney injury following general anaesthesia across three multidisciplinary referral centres and one primary care practice in the UK. Information obtained included signalment, general anaesthesia, surgical procedure and peri-surgical management.
The aim was to characterise common factors after a suspected increase in incidence of post-procedure acute kidney injury in animals without identifiable risk factors.
Emma Rogers-Smith, a resident in internal medicine at Davies Veterinary Specialists and corresponding author for the paper, said: “A suspicion that there was an increase in non-geriatric dogs suffering acute kidney injury (AKI) shortly after elective procedures led to this study.
"Whilst our data supported this suspicion, there was an increase in incidence, the change itself is not statistically significant and so we are unable to be conclusive.
"This study is limited by small sample size and retrospective nature of the data. At this time no definitive causal link between these cases has been found.
"As such, we are urging clinicians with similar experiences in the last 24 months to get in touch. We hope to ascertain if there is any commonality between these cases and, if possible, better define the incidence of AKI in non-geriatric animals following elective procedures.”
Nick Jeffery, editor of JSAP said: “Nowadays, most veterinarians consider general anaesthesia safe in dogs and routinely allay pet-owner concerns. Whilst AKI following general anaesthesia seems to be rare, it is worrying that a specific risk factor was not identified in any dog, despite a wealth of available clinical data. I would urge any veterinarians that have similar cases to contact the authors.”
Any clinicians with similar experiences during the last 24 months should contact Emma Rogers-Smith on emma.rogers-smith@vetspecialists.co.uk.
The full article can be found in the June issue of the Journal of Small Animal Practice, and here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13134
The 'Room For Rabbits' campaign follows research in which 38% of vets said they think rabbits’ environment is the most neglected welfare need1, with over a quarter of the UK’s rabbits being kept in inadequate housing conditions, and almost half of them living alone2.
The RAW survey also found that 90% of vets believe that rabbits’ welfare in the UK is improving3.
Room for Rabbits will throw a spotlight on rabbits’ environment, with a variety of initiatives during RAW including vet blogs and videos on how to adapt bunnies’ housing for all seasons, boredom buster ideas, a competition to encourage owners to create a RAW ‘gold standard’ environment, and downloadable packs containing resources for practices to create their own RAW campaigns.
Holly Castle, Senior Brand Manager at Burgess Pet Care, RAAG member and organisers of RAW, said: “We are delighted that RAW continues to have a positive impact, with our survey showing that 90% of vets believe that the welfare of the UK’s rabbits is improving - but there is always more than we can do.
“Since the previous RAW campaign, we have successfully launched RAAG, which recognises that the welfare of these wonderful creatures needs to be high on the agenda year-round.
"By bringing together the expertise of the RAW partners, RAAG is focused on encouraging everyone involved with rabbits to support the first Good Practice Code for rabbits’ welfare in England to ensure it becomes enshrined in law.
"One of the ways to achieve this is through initiatives like RAW, which is the UK’s largest welfare campaign of its kind.
“We recognise that vets’ practices were really stretched last year due to the Covid-19 pandemic, which meant it was difficult to support campaigns like RAW.
"However, following a surge in demand for rabbit ownership in the UK during the past two years, it is vitally important that we educate more owners than ever before and continue to help improve rabbits’ welfare."
“The veterinary community plays a hugely important role in ensuring that owners have access to the right information, and we are urging practices to throw their support behind this year’s RAW to ensure that we reach as many owners as possible.
Professor Ian Ramsey, Past President of the BSAVA, which endorses RAW, said: "The BSAVA is once again delighted to support RAW and the theme of this year’s campaign.
"Rabbits remain one of the most misunderstood pets in the UK, but we are confident that vets across the UK will again show their support for this important campaign to improve the lives of pet rabbits.”
The RAAG is encouraging vets’ practices to sign up to receive updates about RAW at https://www.rabbitawarenessactiongroup.co.uk/raw-pack-reminder/.
Downloadable RAW vet packs will also be available from 6th June.
The paper details the current and potential uses of this rapidly developing technology, and its benefits and risks.
It provides an introduction to AI and its uses in human medicine, small animal, farm and equine practice, radiology and veterinary education.
It also looks at the potential impact on the wellbeing and working life of veterinary teams.
Results from VetCT’s recent survey on the opinions of AI within the veterinary profession are included in the paper.
Julien Labruyère, Chief Innovation Officer at VetCT, said: “This is a crucial moment in the veterinary industry to ensure we have the knowledge and safeguards in place to apply AI safely, effectively and with confidence to support good clinical practice and ultimately, improve animal welfare.
"This white paper aims to provide a firm foundation for understanding AI and stimulate discussion on how it may impact both people and animals.”
The paper also calls for the development of industry-wide guidance, standards and regulations to safeguard veterinary teams and animal health and welfare as these tools are deployed.
Julien added: “AI development is accelerating rapidly, with global governments and industries racing to regulate to ensure the benefits outweigh the potential negative impacts of this far-reaching technology.
"It’s vital that opinion leaders, organisations and regulators from across the veterinary world come together and develop guardrails so we can have confidence that AI tools will benefit our teams and our patients.”
https://5345458.hs-sites.com/vetct-ai-white-paper
The rationale for completing a course of antibiotics has always been to prevent the growth of drug-resistant bacteria. However, the article says there is little evidence to support this idea, and that in fact, taking antibiotics for longer than necessary presents a greater risk of causing antibiotic resistance.
Responding to article, BVA Junior Vice President John Fishwick said: "We're very aware of the global threat antimicrobial resistance poses to human and animal health, and the UK veterinary profession is committed to the responsible use of antibiotics. Medicines should never be used to compensate for poor husbandry practices and routine habitual prophylactic use in healthy animals to prevent disease is a no-go.
"The article in the BMJ suggests that antibiotics should be used for as short a period as possible, and that we should move away from the concept of following a predetermined course. This may indeed be a very important advance, but it is far too early to determine how this would work in veterinary practice. We need to clearly establish the evidence supporting it.
"We support the researchers’ calls for clinical trials to determine the most effective strategies for antibiotic treatment. Until further studies are conducted, it is too early to change the way we prescribe medicines and vets should continue to prescribe as previously, only when necessary. It is also vital that clients continue to follow the directions given by their vets, both in terms of dosage and duration of treatment, carefully."
The course counts for four hours CPD, split into six short sessions which can be completed in your own time.
Presented by Dr Dan Cripwell BSc (Hons) BVSc CertAVP PgCert (VPS) MRCVS, Advanced Veterinary Practitioner and senior veterinary technical advisor at Jurox, the sessions consist of:
There is a quiz at the end of each module, following which, you can download a CPD certificate.
Suzy Ramsay, head of sales and marketing at Jurox (UK) Limited, said: “We are committed to developing unique and world class anaesthesia and analgesic products and practices within the animal health industry through the provision of up-to-date technical support and education. Our new Jurox Anaesthesia Academy CPD platform will enable veterinary professionals to adopt an evidence-based approach to their anaesthetic product choice and, in turn, help achieve the best possible anaesthetic outcomes for their patients.”
For access to the Jurox Anaesthesia Academy CPD platform, visit https://cpd.jurox.co.uk.
For further information, contact your local Jurox account manager, phone 0800 500 3171 or email customerservice@jurox.co.uk.
Zoetis has announced the launch of Simparica, a once-monthly oral medication for the treatment of flea, tick and mite infestations in dogs beginning at eight weeks of age.
The company says the new product, which comes in the form of a tasty chewable tablet, acts quickly and provides continuous protection for 35 days without losing efficacy at the end of the month.
Simparica is effective against both Ctenocephalides felis and Ctenocephalides canis flea infestations in dogs.² It starts to kill fleas quickly within three hours³ and continues to kill fleas for at least 35 days², making it suitable as part of a treatment strategy for Flea Allergic Dermatitis.
The product also protects dogs against infestations with the most common ticks found to infest dogs in Europe2,4, including Dermacentor reticulatus, the species associated with the disease babesiosis, which has recently been reported in the UK. It’s also the only treatment for Ixodes hexagonus, one of the most prevalent ticks in the UK. The killing effect against Ixodes ricinus starts within 8 hours after a single oral administration and over 96% are killed within 24 hours.4
Zoetis says Simparica is also effective against Rhipicephalus sanguineus, and Sarcoptes scabiei, and that laboratory evidence shows efficacy for Demodex Canis and Otodectes Cynotis.
Zoetis believes that Simparica’s ability to provide continuous protection up to and beyond the monthly treatment period is very important for pet owners. Sixty three per cent of owners confess to giving flea and tick treatment later than when it was due, with the median being 5 days late.¹ Simparica gives vets and forgetful pet owners the peace of mind of extended duration of activity helping to minimise the potential risk of protection gaps.
Ned Flaxman, companion animal business unit director at Zoetis said: "With Simparica, we bring to the market an advanced parasiticide solution, helping to deliver improved client and pet owner satisfaction. The chewable tablets are easy to administer and readily accepted by dogs. But more importantly, Simparica helps vets and dog owners minimise the potential risk of protection gaps, as it acts very fast to kill fleas and ticks and performs for at least 35 days without losing efficacy — well beyond the monthly treatment period.
"With its rapid onset, robust duration of activity and very good safety profile, Simparica is the only oral isoxazoline indicated for four species of ticks in Europe including Ixodes hexagonus and the two species of fleas, dogs are most frequently infested with. Unlike most treatments, Simparica protects from both types of ectoparasites for the same duration."
For more information please speak to your account manager or contact customer support on 0854 300 8034.
Virbac points to how the pandemic has caused a fundamental shift in consumer shopping habits, with e-commerce accounting for more than 30% of retail sales in the UK in 2020 for the first time1.
Alongside the increase in online sales has come an expectation by consumers that all companies should provide a reliable digital service, with 70% saying that they will continue to buy essential goods online post-pandemic2.
At the same time, sales of pet food in the majority of veterinary practices have been hit by the need for social distancing.
Through the new model, when pet owners buy Virbac's low-carb, high protein Veterinary HPM dog and cat food from the company's new web store for home delivery, a commission is paid to the practice.
Remi Mandray, Product Manager at Virbac said: "It’s a win-win for our practices and their clients, who can take advantage of this convenient option to have their pet food delivered to their home, whilst providing the practice with a protected and rewarding business model".
For more information, contact your Virbac Territory Manager.
It's believed that VetSurgeon.org and VetNurse.co.uk, which run on a platform that predates Facebook, may be the first online communities to require good manners.
Under the new policy, anyone who posts anything in the forums which is sarcastic, belittling, snide, rude or unkind towards another member will face immediate removal from the website.
This marks a very radical change to the previous policy in which members were free to say pretty much what they wanted.
VetSurgeon.org Publisher Arlo Guthrie said: "For years, I felt the right to free speech trumped all, and would rarely intervene.
"When I did, the worst anyone faced was a temporary suspension.
"As time has passed, I've realised the limitations of the written word, especially the short-form, hastily-written word, which can cause real distress.
"We all moderate our language offline, it's just a question of realising that we need a different set of standards online, to account for the lack of facial expression and immediacy of reply, and the public nature of the discussion.
Some people have questioned the new policy, and whether it will stifle proper debate.
Arlo added: "I believe not. It is perfectly possible and OK to disagree with someone, and express that disagreement forcefully, without being sarcastic.
"On the contrary, I think that allowing bad manners has a far more chilling effect on free speech, because it scares off opinions from the majority of more moderate members"
Others have asked whether this new policy is the consequence of the new partnership with Improve International, or proposed new laws surrounding social media.
Arlo said: "Again, no. It was a very personal decision I reached after years of wrestling with the problem. It was precipitated by a series of unkind posts and I just thought 'enough's enough'.
"That said, I am really excited about the prospect of working with Improve to grow the community as somewhere its members can come for high quality clinical content and authoritative opinion, which for sure would be hard to achieve if we don't have a friendly, collaborative atmosphere."
Another issue raised about zero tolerance is whether it is fair that there may be no second chance.
Arlo said: "I've tried loads of things over the years. Warnings. Red cards. Suspensions. None of them work. People just push the boundaries.
"But the moment I said 'zero tolerance', it seems people get the message and moderate themselves accordingly."
"I'm delighted. I want people to think of VetSurgeon.org as somewhere everyone can come for authoritative advice and support, confident of a friendly welcome and the highest standards of online behaviour."
Andrea, who is also an EBVS Specialist in Small Animal Internal Medicine, is joining Paragon after returning from a spell in Australia. The transfer fee was not disclosed.
Andrea graduated from Bristol in 2011 and became a Specialist in 2017. She said: "I'm so pleased to be returning to my beautiful home county of Yorkshire and joining the brilliant team at Paragon.
"Internal medicine will be my key area and my main interests are infectious diseases and post graduate clinical teaching."
Andrea represented England youth at basketball between 2000 and 2002, starring in tournaments in Hungary and Italy, and her passion for sport is still high on her list of priorities.
She added: "Now I’m back home I’m looking to join a triathlon club and will attempt to master the ukulele, which I recently began playing."
Paragon managing director, Ian Monteith, said: "Andrea is the fifth high-calibre specialist addition we’ve made in the past six months which illustrates our dedication to delivering the highest level of care and treatment to our patients."